Related Experiment Video

Updated: Jun 17, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants

    Paediatrics & Child Health
    |January 5, 2010
    PubMed

    Insights

    Routine systemic dexamethasone is not recommended for preventing or treating chronic lung disease in very low birth weight infants. This statement guides healthcare professionals on corticosteroid use in neonates and young infants.

    Area of Science:

    • Neonatal Medicine
    • Pediatric Pulmonology
    • Pharmacology

    Background:

    • Chronic lung disease (CLD) is a significant concern in neonates, particularly those with very low birth weight (VLBW).
    • Postnatal corticosteroids are used to manage evolving or established CLD.
    • Evidence on the short and long-term effects of these treatments is crucial for clinical decision-making.

    Purpose of the Study:

    • To review the effects of systemic and inhaled postnatal corticosteroids.
    • To provide recommendations for corticosteroid use in VLBW infants.
    • To guide healthcare professionals in managing CLD in neonates.

    Main Methods:

    • Systematic review of existing literature on postnatal corticosteroid use.
    • Analysis of short-term and long-term outcomes.
    • Formulation of clinical recommendations based on evidence.

    Main Results:

    • Routine use of systemic dexamethasone for CLD prevention or treatment in VLBW infants is not advised.
    • Inhaled corticosteroids may have a role, but require careful consideration.
    • Long-term effects of systemic corticosteroids necessitate caution.

    Conclusions:

    • Healthcare professionals should carefully weigh the risks and benefits of postnatal corticosteroids.
    • Non-routine or judicious use of specific corticosteroid formulations may be considered.
    • Further research is needed to optimize CLD management in VLBW infants.

    Keywords:
    Chronic lung diseaseCorticosteroidsInfantNewbornPretermVery low birth weight

    Related Concept Videos

    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

    Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
    ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

    Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
    Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...